BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2058533)

  • 1. Treatment of tuberculosis.
    Lordi GM; Reichman LB
    Am Fam Physician; 1991 Jul; 44(1):219-24. PubMed ID: 2058533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis therapy 1990].
    Villiger B
    Schweiz Rundsch Med Prax; 1990 May; 79(21):670-4. PubMed ID: 2190295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of tuberculosis in Australia.
    Benn RA; Woolcock AJ
    Med J Aust; 1985 Dec 9-23; 143(12-13):602-5. PubMed ID: 3831750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
    Brändli O; Dreher D; Morger D
    Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis in the 1990's: resurgence, regimens, and resources.
    Pust RE
    South Med J; 1992 Jun; 85(6):584-93. PubMed ID: 1604386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of tuberculosis].
    Dautzenberg B
    Rev Prat; 1996 Jun; 46(11):1350-5. PubMed ID: 8794618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course therapy for tuberculosis in infants and children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1994 Apr; 150(8):1233-9. PubMed ID: 8162546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant tuberculosis: etiology, management and prevention.
    O'Brien RJ
    Semin Respir Infect; 1994 Jun; 9(2):104-12. PubMed ID: 7973169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growing shadow of tuberculosis.
    Nary G
    J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):26-7. PubMed ID: 11362486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of tuberculosis].
    Eier A; Grass S
    Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of a short 6 month therapeutic coursefor HIV infected tuberculosis patients in Abidjan, Côte d'Ivoire].
    Domoua K; N'Dhatz M; Coulibaly G; Traore F; Koffi J; Achi V; Daix T; Ouattara Y; Ouedraogo M; Beugre LK; Konan JB; Coulibaly V; Coulibaly IM; Yapi A
    Bull Soc Pathol Exot; 1998; 91(4):312-4. PubMed ID: 9846224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compliance, efficacy and tolerability of the therapeutic regimen recommended by National Consensus on Tuberculosis].
    Colmenero JD; García-Ordoñez MA; Sebastián MD; Pérez-Ruiz E; Sánchez-Lora J; Sánchez-González J; Bentabol G; Juárez C
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):129-33. PubMed ID: 9235051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current tuberculosis treatment regimens. Choosing the right one for your patient.
    Pérez-Stable EJ; Hopewell PC
    Clin Chest Med; 1989 Sep; 10(3):323-39. PubMed ID: 2673644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.